This is the fourth post in a blog mini-series from the Dengue Vaccine Initiativeabout the collaborative work being done to ensure future access to dengue vaccines in developing nations.

Late last week, the GAVI Alliance board announced its plan to fund the introduction of vaccine

Financing research and development (R&D) for neglected tropical disease (NTDs) is a big challenge. The problem? Market failure.

This week in the Global Post, Dr. Fred Were, a pediatrician and specialist in neonatal medicine and National Chairman of the Kenya Pediatric Association (KPA), wrote about the dengue outbreak that swept his country in October. Dr.

Pages